This chart should really say it all. This stock is in the midst of a parabolic bounce. It may see some correction on the way but we definitely feel this stock fits into our niche of low risk penny stocks that can offer explosive gains. This biotech company has many patents for it's stem cell technology and is a easy buyout candidate on pending FDA approval. They just announced Michael Hershman as Chairman Of The Board of Directors. Which is very big important news. Who is Michael Hershman ?